Rational Pharmacotherapy in Cardiology

Advanced search

Possibilities of Evaluating the Dynamics of Left Ventricular Perfusion and Contractility in Patients with Chronic Heart Failure after Implantation of a Heart Contractility Modulator Using Perfusion Single-Photon Emission Computed Tomography

Full Text:


Perfusion scintigraphy and single-photon emission tomography of the myocardium are promising methods for complex assessment of the state of the left ventricle myocardium in patients with chronic heart failure. These methods of nuclear cardiology can be performed in patients with reduced renal function, as well as the presence of implanted devices such as implantable cardioverters-defibrillators, resynchronizing devices and cardiac modulating therapy, which is their undeniable advantage. The reproducibility of the method is ensured bu fully automated calculation of parameters of myocardial perfusion and contractility. To date, there are no data in the literature on the use of nuclear cardiology methods as an imaging technique in patients with cardiac contractility modulation devises. This paper describes the current possibilities and prospects of nuclear medicine methods in patients with chronic heart failure after implantation of a heart contractility modulator.

About the Authors

V. A. Amanatova
National Medical Research Center of Cardiology
Russian Federation

Valeriya A. Amanatova - eLibrary SPIN 1058-0239


A. A. Safiullina
National Medical Research Center of Cardiology
Russian Federation

Alfiya A. Safiullina - eLibrary SPIN 7118-1198


T. M. Uskach
National Medical Research Center of Cardiology; Russian Medical Academy of Continuous Professional Education
Russian Federation

Tatiana M. Uskach - eLibrary SPIN 8752-9657


A. A. Ansheles
National Medical Research Center of Cardiology
Russian Federation

Alexey A. Ansheles - eLibrary SPIN 7781-6310


V. B. Sergienko
National Medical Research Center of Cardiology
Russian Federation

Vladimir B. Sergienko - eLibrary SPIN 4918-3443


S. N. Tereshchenko
National Medical Research Center of Cardiology; Russian Medical Academy of Continuous Professional Education
Russian Federation

Sergey N. Tereshchenko - eLibrary SPIN 9556-2575



1. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Rev Esp Cardiol (Engl Ed). 2016;69(12):1167. DOI:10.1016/j.rec.2016.11.005.

2. Fomin IV. chronic heart failure in the Russian Federation: what we know and what to do. Russian Journal of Cardiology. 2016;(8):7-13 (In Russ.) DOI:10.15829/1560-4071-2016-8-7-13.

3. Mareev VY, Fomin IV, Ageev FT, et al. Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF). Diagnosis, prevention and treatment. Kardiologiia. 2018;58(6S):8-158 (In Russ.) DOI:10.18087/cardio.2475.

4. Satlykova DF, Shashkova NV, Gerasimova VV, et al. Comparative evaluation of remodeling and left ventricular systolic and diastolic volumetric hemodynamic parameters in patients with preserved and impaired ejection fraction by 4D tomoventriculography. Russian Heart Failure Journal. 2013;14(4):171-80 (In Russ.) DOI:10.18087/rhfj.2013.4.1811.

5. Sachpekidis C, Sachpekidis V, Moralidis E, Arsos G. Equilibrium radionuclide ventriculography: still a clinically useful method for the assessment of cardiac function? Hell J Nucl Med. 2018;21(3):213-20.

6. Underwood SR, Anagnostopoulos C, Cerqueira M, et al. Myocardial perfusion scintigraphy: the evi-dence. Eur J Nucl Med Mol Imaging. 2004:31(2);261-91. DOI:10.1007/s00259-003-1344-5.

7. Knuuti J, Wijns W, Saraste A, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J. 2020;41(3):407-77. DOI:10.1093/eurheartj/ehz425.

8. Ghosh N, Rimoldi OE, Beanlands RS, Camici PG. Assessment of myocardial ischaemia and viability: role of positron emission tomography Eur Heart J. 2010;31(24):2984-95. DOI:10.1093/eurheartj/ehq361.

9. Lishmanov YuB, Zavadovsky KV, Gulya MO, et al. Dual isotope myocardial SPECT with 99mTc-MIBI and 123I-BMIPP. Siberian Medical Journal. 2015;30(4):27-31 (In Russ.)

10. Hambye AS, Dobbeleir AA, Vervaet AM, et al. BMIPP imaging to improve the value of sestamibi scintigraphy for predicting functional outcome in severe chronic ischemic left ventricular dysfunction. J Nucl Med. 1999;40(9):1468-76.

11. Shipulin VV, Saushkin VV, Pryakhin AS, et al. The value of myocardium perfusion imaging in assessment of patients with ischemic cardiomyopathy. REJR. 2019;9(3):155-75 (In Russ.) DOI:10.21569/2222-7415-2019-9-3-155-175.

12. Borggrefe MM, Lawo T, Butter C, et al. Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure. Eur Heart J. 2008;29(8):1019-28. DOI:10.1093/eurheartj/ehn020.

13. Kadish A, Nademanee K, Volosin K, et al. A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure. American Heart Journal. 2011;161(2):329-337.e2. DOI:10.1016/j.ahj.2010.10.025.

14. Abraham WT, Nademanee K, Volosin K, et al. Subgroup Analysis of a Randomized Controlled Trial Evaluating the Safety and Efficacy of Cardiac Contractility Modulation in Advanced Heart Failure. Journal of Cardiac Failure. 2011;17(9):710-7. DOI:0.1016/j.cardfail.2011.05.006.

15. Schau T, Seifert M, Meyhofer J, et al. Long-term outcome of cardiac contractility modulation in patients with severe congestive heart failure. Europace. 2011;13(10):1436-44. DOI:10.1093/europace/eur153.

16. Kuschyk J, Roeger S, Schneider R, et al. Efficacy and survival in patients with cardiac contractility modulation: Long-term single center experience in 81 patients. International Journal of Cardiology. 2015;183:76-81. DOI:10.1016/j.ijcard.2014.12.178.

17. Kloppe A, Lawo T, Mijic D, et al. Longterm survival with Cardiac Contractility Modulation in patients with NYHA II or III symptoms and normal QRS duration. International Journal of Cardiology. 2016;209:291-5. DOI:10.1016/j.ijcard.2016.02.001.

18. Liu M, Fang F, Luo XX, et al. Improvement of long-term survival by cardiac contractility modulation in heart failure patients: A case-control study. International Journal of Cardiology. 2016;206:122-6. DOI:10.1016/j.ijcard.2016.01.071.

19. Grigioni F, Carinci V, Boriani G, et al. Accelerated QRS widening as an independent predictor of cardiac death or of the need for heart transplantation in patients with congestive heart failure. The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation. 2002;21(8):899-902. PMID: 12163090.

20. Roger S, Michels J, Heggemann F et al. Long term impact of cardiac contractility modulation on QRS duration. Journal of Electrocardiology. 2014;47(6):936-40. DOI:10.1016/j.jelectrocard.2014.08.011.

21. Nagele H, Behrens S, Eisermann C. Cardiac contractility modulation in non-responders to cardiac re-synchronization therapy. Europace. 2008;10(12):1375-80. DOI:10.1093/europace/eun257.

22. Abi-Samra F, Gutterman D. Cardiac contractility modulation: a novel approach for the treatment of heart failure. Heart Failure Reviews. 2016;21(6):645-60. DOI:10.1007/s10741-016-9571-6.

23. Kloppe A, Boesche L, Aweimer A. et al. Acute and short term safety and feasibility of the new OPTIMIZER SMART-system: Is it reasonable to avoid an atrial lead? EP Europace. 2018;20(suppl_1):i48- i48. DOI:10.1093/europace/euy015.128.

24. Revishvili ASh, Artyukhina EA, Amiraslanov A. Yu. et al. The first experience of treatment of patients with chronic heart failure using cardiac contractility modulation device. Journal of Arrhythmology. 2017;(90):12-8 (In Russ.)

25. Mando R, Goel A, Habash F, et al. Outcomes of Cardiac Contractility Modulation: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Hindawi Cardiovascular Therapeutics. 2019;9769724:10. DOI:10.1155/2019/9769724.

26. Duncker D, Veltmann C. Device therapy in heart failure with reduced ejection fraction—cardiac resynchronization therapy and more. Herz. 2018;43(5):41522. DOI:10.1007/s00059-018-4710-6.

27. Atabekov TA, Batalov RE, Krivolapov SN, et al. A new approach in cardioverter-defibrillator implantation in patients with coronary artery disease. Russian Journal of Cardiology. 2019;(3):32-8 (In Russ.). DOI:10.15829/1560-4071-2019-3-32-38.

28. Flachskampf FA. Kursbuch Echokardiografie: Untersicht der Leitlinien der Deutschen Gesellschaft fur Kardiologie. Berlin: Thieme; 2011.

29. Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald's heart disease: a textbook of cardiovascular medicine. 11th ed. Philadelphia, PA: Elsevier/Saunders: Elsevier; 2018.

30. Bugri ME, Satlykova DF, Mareev VYu, Sergienko VB. D-tomoventriculography - a novel method iniagnostics of contractile function of the heart. Kardiologiia. 2009;6:54-60 (In Russ.)


For citations:

Amanatova V.A., Safiullina A.A., Uskach T.M., Ansheles A.A., Sergienko V.B., Tereshchenko S.N. Possibilities of Evaluating the Dynamics of Left Ventricular Perfusion and Contractility in Patients with Chronic Heart Failure after Implantation of a Heart Contractility Modulator Using Perfusion Single-Photon Emission Computed Tomography. Rational Pharmacotherapy in Cardiology. 2021;17(2):263-269. (In Russ.)

Views: 438

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 1819-6446 (Print)
ISSN 2225-3653 (Online)